PREVIOUS QUESTION:

 

NEXT QUESTION:

 

Do biologics for Crohn's disease have risks?

ANSWER

In most cases, biologics cause fewer problems than other drugs used for Crohn's disease. In some instances, there can be serious side effects.

Also, there is a risk for infections and certain types of cancer in people who take these drugs. Talk with your doctor about which medicine is right for you.

No matter which one your doctor prescribes, they'll watch you carefully.

Before you take one of these drugs, let your doctor know if you have a heart condition or a disease that affects your nervous system.

SOURCES:

Crohn's & Colitis Foundation of America: "Immunomodulators," "Crohn's Disease Medication Options," "Biologic Therapies."

Beth Israel Deaconess Medical Center: "What are the treatments for Crohn's Disease?"

FDA: “FDA approves Amjevita, a biosimilar to Humira.”

National Institute of Diabetes and Digestive and Kidney Diseases: "Crohn's Disease."

Reviewed by Neha Pathak on October 8, 2019

SOURCES:

Crohn's & Colitis Foundation of America: "Immunomodulators," "Crohn's Disease Medication Options," "Biologic Therapies."

Beth Israel Deaconess Medical Center: "What are the treatments for Crohn's Disease?"

FDA: “FDA approves Amjevita, a biosimilar to Humira.”

National Institute of Diabetes and Digestive and Kidney Diseases: "Crohn's Disease."

Reviewed by Neha Pathak on October 8, 2019

NEXT QUESTION:

What are side effects of biologics?

WAS THIS ANSWER HELPFUL

"ALEXA, ASK WEBMD"

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.